Trade AbbVie ^ABBV

3,545 AbbVie Inc. $ABBV Shares Purchased by IRON Financial LLC

BG Investment Services LLC Acquires 6,371 Shares of AbbVie Inc. $ABBV

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Trim from Wedbush - Zolmax

Avalo Therapeutics (NASDAQ:AVTX) Stock Gets Price Target Reduction from BTIG Research - Markets Daily

Erste Group Bank Has Negative View of AbbVie FY2027 Earnings

Teva (TEVA) Gets a Buy from Piper Sandler

AbbVie Inc. $ABBV Stake Boosted by One Wealth Capital Management LLC - Zolmax

AbbVie Inc. $ABBV Holdings Raised by One Wealth Capital Management LLC

AbbVie Inc. $ABBV Stake Lessened by Sterling Capital Management LLC

AbbVie Inc. $ABBV Stock: Evergreen Capital Management LLC Grows Stake

AbbVie Inc. $ABBV Stock Sold by Capital Investment Advisors LLC

AbbVie Inc. $ABBV Holdings Lessened by Wedbush Securities Inc. - Stock Observer

AbbVie Inc. $ABBV Stock Position Boosted by Royal Fund Management LLC

AbbVie Inc. $ABBV Stock: Sepio Capital LP Boosts Position

49,252 Shares in AbbVie Inc. $ABBV Bought by NBT Bank N.A.

AbbVie Inc. $ABBV Stock Bought by Root Financial Partners LLC - Daily Political

AbbVie Inc. (NYSE:ABBV) Stock Has Average Price Target of $279.86

AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?

Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different

AbbVie FY2026 Earnings Forecast Lowered by Erste Group Bank

ADARx Pharmaceuticals (ADRX): Can Its SiRNA Pipeline Unlock Multiple Growth Opportunities?

AbbVie Inc. $ABBV Stock Acquired by Crescent Grove Advisors LLC - Markets Daily

AbbVie Inc. $ABBV Stock: Lmcg Investments LLC Decreases Stake - Markets Daily

AbbVie Inc. $ABBV Stock Sold by Lmcg Investments LLC

AbbVie Inc. $ABBV Stock Sold by Vest Financial LLC

6,790 AbbVie Inc. $ABBV Shares Sold by AMF Tjanstepension AB

AbbVie's Lutikizumab Demonstrates Efficacy in Treating Hidradenitis Suppurativa, Paving Way for Weight-Loss Drug Combination, ETPharma

AbbVie (ABBV) Projected to Announce Quarterly Earnings on Friday

Ophthalmology Sector Emerges as Must-Win Battleground for Global Pharma: Eli Lilly, Merck & Co., AbbVie, Innovent Biologics, Hengrui Medicine and Leading Players Enter the Market

AbbVie Inc. $ABBV Stock Holdings Lessened by Investment House LLC - Stock Observer

Top Biotech Stocks To Consider - October 22nd - Markets Daily

AbbVie (ABBV) Reports Positive INTREPID Trial Results but Faces

AbbVie's Lutikizumab Meets Pre-specified Endpoints In Phase 3 Hidradenitis Suppurativa Trial

Jim Cramer and Ken Fisher Like This Healthcare Stock

JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up

AbbVie Inc. $ABBV Stock Acquired by Sowell Financial Services LLC

Sawyer & Company Inc Purchases New Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Nisa Investment Advisors LLC

Crossmark Global Holdings Inc. Purchases 13,446 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Newly Purchased by Capstone Capital Management Ltd

2,400 AbbVie Inc. $ABBV Shares Purchased by Newman Dignan & Sheerar Inc. - Stock Observer

Sowell Financial Services LLC Buys 3,985 Shares of AbbVie Inc. $ABBV - Daily Political

Multiple myeloma in the Netherlands: 35-year trends in incidence and survival

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial

Alpha male in HS? Abbvie phase III data subdue Avalo shares​ | BioWorld

AbbVie's HArmonyCa Shows Midface Improvement In GLP-1 Patient Analysis; Stock Down

AbbVie vs. AstraZeneca: Which Pharma Giant Has the Stronger Earnings Growth Story?

AbbVie Highlights New HArmonyCa Results In Patients Using GLP-1 Weight-Loss Drugs

Forget Social Security: 5 High-Yield Stocks Retirees Are Buying Instead

AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian Cancer

Top 10 Stocks Jim Cramer and Billionaire Ken Fisher Like

3,811 AbbVie Inc. $ABBV Shares Sold by Prime Capital Investment Advisors LLC

AbbVie Inc. $ABBV Stock Sold by Sumitomo Mitsui DS Asset Management Company Ltd

AbbVie Inc. $ABBV Stock: Bank Pictet & Cie Europe AG Reduces Position

Biotech Stocks To Keep An Eye On - October 18th - Stock Observer

Top Global Life Science Funds 2024: Unprecedented Massive Funding Surge Creates Excess Capital Overflow

McLaren Teams Up With AbbVie Before Formula 1 United States GP At COTA

AbbVie (ABBV) Posts Fresh Crohn's Remission Data Ahead Of Its Biggest ESMO Reveal

AbbVie's SKYRIZI Gets Health Canada Approval For Children With Moderate To Severe Plaque Psoriasis

AbbVie (ABBV) - Investment Analysts' Recent Ratings Updates - Daily Political

Pharmaceutical Stocks To Consider - October 20th - Daily Political

Greg Jennings LLC Makes New Investment in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Stock Holdings Cut by RWQ Financial Management Services Inc.

AbbVie (ABBV) Receives a Buy from RBC Capital

Parkinson's Disease Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and ROA by DelveInsight | AbbVie, Pfizer, Novartis, F. Roche, Kissei Pharma, AstraZeneca, Prevail Therapeutics, Amneal | ABNewswire

AbbVie Inc. $ABBV Stock: Gimbal Financial Boosts Position

AbbVie Inc. $ABBV Stock Holdings Trimmed by BDF Gestion

AbbVie (ABBV) Unveils Phase 2a Crohn's Data And Flags 2026 ESMO Readouts

AbbVie vs. Bristol Myers: Is AbbVie's Valuation Premium Worth Paying?

Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead

AbbVie Inc. $ABBV Stock: Generali Investments Management Co LLC Cuts Stake

AbbVie's Dual-Targeting Therapy Shows Higher Remission Rates In Mid-Stage Crohn's Disease Study

AbbVie announces new, updated data from solid tumor portfolio at ESMO 2026

AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio | Morningstar

AbbVie presents 20 scientific abstracts from its IBD portfolio

Best Healthcare Stocks To Keep An Eye On - October 18th - Stock Observer

AbbVie Inc. $ABBV Stock Sold by Fulcrum Wealth Advisors LLC - Markets Daily

AbbVie Inc. $ABBV Position Increased by TD Waterhouse Canada Inc.

AbbVie Inc. $ABBV Holdings Lowered by St. Louis Financial Planners Asset Management LLC - Stock Observer

ShankerValleau Wealth Advisors Inc. Makes New $546,000 Investment in AbbVie Inc. $ABBV - Stock Observer

Healthcare Stocks To Consider - October 17th - Markets Daily

AbbVie's Dividend Keeps Climbing. Is It Still a Buy for Income Investors?

Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle

AbbVie Inc. $ABBV Stock Sold by Cardinal Capital Management Inc.

AbbVie Inc. $ABBV Shares Acquired by Cyndeo Wealth Partners LLC

BFI Infinity Ltd. Makes New $4.16 Million Investment in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Banque Pictet & Cie SA

Cantor Fitzgerald Investment Advisors L.P. Sells 2,450 Shares of AbbVie Inc. $ABBV - Daily Political

Pfizer vs. AbbVie: Is the Cheaper Pharma Stock Really the Better Investment?

AbbVie vs. Merck: Which Pharma Stock Offers Better Value?

Trade Tracker: Kevin Simpson buys AbbVie

AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive?

Pound to Rand Forecast: Can GBP/ZAR Break Above 22?

CoreWeave Stock Forecast 2026–2030: Can CRWV Recover From the AI Debt Sell-Off?

Nebius Stock Price Prediction 2026–2030: Can AI Cloud Growth Justify the Cost?

Eli Lilly Stock Forecast 2026–2030: Can LLY Break Above $1,300 After Its 7% Five-Session Rally?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

Advanced CFD Trading Tools Review: Which Tools Can Improve Your Trading Decisions?

Dow Advances on Value Rotation While Tech Sell-Off and Plunging Crude Drag S&P 500, Nasdaq Lower

Gold Price Today: Bullion Holds Below $4,000 Ahead of Fed Decision

Microsoft Earnings Preview: Can Azure Growth Justify Rising AI Spending?

US Dollar Index Edges Lower Ahead of Fed Decision and Big Tech Earnings

Fed Rate Decision Preview: Will Kevin Warsh Hold Rates at 4% and Signal a December Hike?

Bitcoin Price Today Falls Below $80,000 as ETF Outflows and Liquidations Deepen the Sell-Off

Gold Price Forecast This Week: Can XAU/USD Reclaim $4,000 Before the Fed Decision?

Oil Prices Retreat as Brent Holds Near $115 Amid Saudi Supply Risks

Gold Price Today: XAU/USD Hovers Near $4,015 After Sharp Sell-Off